Fig 5. Antimony susceptibility of promastigotes and amastigotes form of Leishmania species responsible collected in human (visceral or cutaneous leishmaniasis) in dogs (CanL), rodent (L. Rodent) and sandflies (L. Phleb).

SbIII Susceptibility of isolates from human CL and VL, dogs (CanL), rodent (L. Rodent) and sandflies (L. Phleb) (A). SbV Susceptibility of isolates from human CL and VL, and dogs (CanL) (B). Frequency of S- Leishmania isolates from human CL and VL, and Dogs (CanL) (IC50 above the calculated SbIII or Sb(V)-ECOFF values) (C). In vitro SbIII susceptibility of L. major, L. killicki, L. infantum parasites. L. infantum isolated from humans VL($▲$) human CL ($◆$) or dogs ($▲$) (D). In vitro SbV Susceptibility of intramacrophagic amastigotes of L. major, L. killicki and L. infantum, from human VL ($▲$) CL (▲) or Dogs ($▲$) (E). Frequency of S- Leishmania isolates of L. major, L. killicki or L. infantum (IC50 above the calculated SbIII or Sb(V)-ECOFFvalues) (F).